Novartis Aktie
101,50
EUR
+2,34
EUR
+2,36
%
94,03
CHF
+1,30
CHF
+1,40
%
Kursziele der Novartis-Aktie in CHF
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Novartis-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 89,00 CHF | -5,35% | 16.05.2025 | |
| Goldman Sachs Group Inc. | 95,00 CHF | +1,03% | 01.05.2025 | |
| Deutsche Bank AG | 115,00 CHF | +22,30% | 30.04.2025 | |
| DZ BANK | - | - | 30.04.2025 | |
| Jefferies & Company Inc. | 100,00 CHF | +6,35% | 29.04.2025 | |
| UBS AG | 104,00 CHF | +10,60% | 29.04.2025 | |
| Bernstein Research | 115,00 CHF | +22,30% | 29.04.2025 | |
| JP Morgan Chase & Co. | 95,00 CHF | +1,03% | 07.04.2025 | |
| Barclays Capital | 85,00 CHF | -9,60% | 21.11.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | - |
| Bayer | 1 | 8 | 0 | 25,51 EUR | +2,97% |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,96 EUR | +42,86% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 5 | 1 | 16,30 GBP | +8,16% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 165,86 EUR | +42,98% |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +6,08% |
| Pfizer Inc. | 3 | 3 | 0 | 28,80 USD | +22,61% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 279,75 CHF | +5,37% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,12 EUR | +31,85% |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |